| scholarly article | Q13442814 |
| P50 | author | Qiang You | Q87845746 |
| P2093 | author name string | Ting Zhao | |
| Xiaoren Zhang | |||
| Yingchang Li | |||
| Zhongping Su | |||
| P2860 | cites work | Chitinase 3-like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis | Q93095797 |
| N-Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor α2 | Q94660156 | ||
| Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology | Q95721129 | ||
| A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry | Q36884006 | ||
| Plasma YKL-40: a BMI-independent marker of type 2 diabetes | Q36943769 | ||
| YKL-40 tissue expression and plasma levels in patients with ovarian cancer | Q21260376 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans | Q24291240 | ||
| Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma | Q24295370 | ||
| Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway | Q24298961 | ||
| Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes | Q24303575 | ||
| Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system | Q24310081 | ||
| The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 | Q24310131 | ||
| Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages | Q24315996 | ||
| Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function | Q24319020 | ||
| Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family | Q24319994 | ||
| The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways | Q24534189 | ||
| A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers | Q24595527 | ||
| Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer | Q24604176 | ||
| Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3 | Q24624887 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer | Q26853189 | ||
| Chitin is endogenously produced in vertebrates | Q27316365 | ||
| Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution | Q27317208 | ||
| Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39 | Q27641650 | ||
| Matrix elasticity directs stem cell lineage specification | Q27860761 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization | Q28142346 | ||
| Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion | Q28142815 | ||
| Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity | Q28142936 | ||
| gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells | Q28178254 | ||
| High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival | Q28190695 | ||
| CD44: from adhesion molecules to signalling regulators | Q28201701 | ||
| Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease | Q28205002 | ||
| YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas | Q48956095 | ||
| Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker | Q49145962 | ||
| Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer. | Q49920011 | ||
| Chitinase-3-like 1 is a biomarker of acute kidney injury and mortality in paediatric severe malaria | Q49962999 | ||
| Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells | Q50083808 | ||
| Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. | Q50088162 | ||
| Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy | Q50142277 | ||
| Breast Regression Protein-39/Chitinase 3-Like 1 Promotes Renal Fibrosis after Kidney Injury via Activation of Myofibroblasts | Q50231479 | ||
| Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease | Q50471605 | ||
| The cell wall polysaccharide metabolism of the brown alga Ectocarpus siliculosus. Insights into the evolution of extracellular matrix polysaccharides in Eukaryotes | Q50570948 | ||
| Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease | Q50802846 | ||
| Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease. | Q50888668 | ||
| Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis | Q51067922 | ||
| The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients. | Q51315323 | ||
| Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia. | Q51834726 | ||
| YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. | Q51943807 | ||
| Early detection and prognosis of ovarian cancer using serum YKL-40. | Q52088111 | ||
| Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. | Q52176115 | ||
| Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. | Q52619982 | ||
| Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance. | Q53067238 | ||
| Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases. | Q53208202 | ||
| Serum YKL-40 as a marker for cervical adenocarcinoma. | Q53209904 | ||
| Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility. | Q53319037 | ||
| The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. | Q53622506 | ||
| Serum YKL-40 and bone marrow angiogenesis in multiple myeloma. | Q55465518 | ||
| YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. | Q55469339 | ||
| Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. | Q55469941 | ||
| Plasma level of YKL-40 correlates with the severity of coronary atherosclerosis assessed with SYNTAX score | Q57286231 | ||
| An association between YKL-40 and type 2 diabetes in psychotic disorders | Q57452552 | ||
| Endogenous HLA–DR–restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint | Q57752656 | ||
| Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer | Q57975577 | ||
| YKL-40 levels and atrial fibrillation in the general population | Q58007561 | ||
| A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection | Q58098412 | ||
| High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival | Q58175683 | ||
| Clusterin plays an important role in hepatocellular carcinoma metastasis | Q58321603 | ||
| Chitinase 3-like 1 protein plays a critical role in RSV-induced airway inflammation | Q58591824 | ||
| Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer | Q58777985 | ||
| YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis | Q58778146 | ||
| K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression | Q58788519 | ||
| Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1 | Q58796710 | ||
| Chitinase 3-like 1 protein plays a critical role in respiratory syncytial virus-induced airway inflammation | Q60153688 | ||
| Genetic variants inCHI3L1influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population | Q60585747 | ||
| Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction | Q61912598 | ||
| High YKL-40 levels predict mortality in patients with type 2 diabetes | Q61948374 | ||
| Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis | Q63432590 | ||
| Diurnal, Weekly, and Long-Time Variation in Serum Concentrations of YKL-40 in Healthy Subjects | Q63727810 | ||
| Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer | Q63753441 | ||
| Decreased Lung Tumor Development in SwAPP Mice through the Downregulation of CHI3L1 and STAT 3 Activity via the Upregulation of miRNA342-3p | Q64242366 | ||
| Functional study of the association of polymorphisms with asthma susceptibility in the Southwest Chinese Han population | Q64262448 | ||
| Tumor Angiogenesis | Q69374811 | ||
| Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies | Q28205489 | ||
| High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival | Q28215091 | ||
| YKL-40--a novel biomarker in clinical practice? | Q28244771 | ||
| Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation | Q28245478 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells | Q28586972 | ||
| Tissue cells feel and respond to the stiffness of their substrate | Q29547613 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Vasculogenic mimicry and tumor angiogenesis | Q30498765 | ||
| miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development | Q30596758 | ||
| YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor | Q33343967 | ||
| The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene | Q33546894 | ||
| Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy | Q33561644 | ||
| Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis | Q33576348 | ||
| Functions of hyaluronan in wound repair | Q33609847 | ||
| Resveratrol represses YKL-40 expression in human glioma U87 cells | Q33732189 | ||
| Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics | Q33769278 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints | Q34012380 | ||
| Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells | Q34052057 | ||
| Antibiotics that inhibit fungal cell wall development | Q34059193 | ||
| Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients | Q34088928 | ||
| Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. | Q34165054 | ||
| The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. | Q34269049 | ||
| Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel | Q34287664 | ||
| Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma | Q34412656 | ||
| YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease | Q34447497 | ||
| Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion | Q34451438 | ||
| Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease | Q34468219 | ||
| Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway | Q34505974 | ||
| A chitinase-like protein in the lung and circulation of patients with severe asthma | Q34713773 | ||
| Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
| Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease | Q34834538 | ||
| Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing | Q34945220 | ||
| Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma | Q37036167 | ||
| YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria | Q37067140 | ||
| Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis | Q37126258 | ||
| Serum YKL-40 Levels in Patients with Gastric Cancer | Q37218917 | ||
| IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses | Q37264739 | ||
| Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis | Q37273123 | ||
| YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? | Q37334247 | ||
| Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease | Q37339883 | ||
| Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease | Q37345484 | ||
| Vasculogenic mimicry in small cell lung cancer | Q37408684 | ||
| Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice. | Q37413102 | ||
| Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma | Q37537572 | ||
| YKL-40 Level and Hypertension Incidence: A Population-Based Nested Case-Control Study in China | Q37556137 | ||
| Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. | Q37599022 | ||
| Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line | Q37607921 | ||
| Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein | Q37618668 | ||
| YKL-40--an emerging biomarker in cardiovascular disease and diabetes | Q37636543 | ||
| Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. | Q37705125 | ||
| Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2 | Q37705711 | ||
| Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity | Q37734258 | ||
| Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. | Q37807414 | ||
| Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling | Q38294459 | ||
| Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein E-knockout mice by chitinase 3-like 1 gene silencing | Q38367958 | ||
| Role of chitinase-like proteins in cancer. | Q38687563 | ||
| YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition | Q38693620 | ||
| YKL-40 protein in osteosarcoma tumor tissue | Q38785342 | ||
| CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis | Q38805517 | ||
| Co-Expression and Co-Localization of Cartilage Glycoproteins CHI3L1 and Lubricin in Osteoarthritic Cartilage: Morphological, Immunohistochemical and Gene Expression Profiles | Q38895007 | ||
| MicroRNA-24 Modulates Staphylococcus aureus-Induced Macrophage Polarization by Suppressing CHI3L1. | Q38902190 | ||
| Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases | Q38915171 | ||
| Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis | Q38928339 | ||
| YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line | Q38993594 | ||
| Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. | Q38995256 | ||
| Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events | Q35021964 | ||
| IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer | Q35064635 | ||
| Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy | Q35083970 | ||
| Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis | Q35121499 | ||
| YKL-40 levels are independently associated with albuminuria in type 2 diabetes | Q35130280 | ||
| Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia | Q35168063 | ||
| Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers | Q35527112 | ||
| Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation. | Q35530893 | ||
| Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study | Q35548928 | ||
| Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions | Q35549462 | ||
| Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis | Q35549775 | ||
| Two closely related human members of chitinase-like family, CHI3L1 and CHI3L2, activate ERK1/2 in 293 and U373 cells but have the different influence on cell proliferation | Q35578736 | ||
| YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer | Q35746711 | ||
| Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis | Q35763932 | ||
| Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model | Q35783730 | ||
| Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer | Q35791353 | ||
| CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis | Q35802388 | ||
| YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C | Q35823055 | ||
| Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40. | Q35828331 | ||
| Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease | Q36040475 | ||
| Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort | Q36071742 | ||
| Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population. | Q36071889 | ||
| Fibronectin fragment-induced expression of matrix metalloproteinases is mediated by MyD88-dependent TLR-2 signaling pathway in human chondrocytes | Q36276352 | ||
| Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy | Q36414978 | ||
| Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung | Q36549088 | ||
| Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients | Q36570193 | ||
| Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function | Q36574753 | ||
| Serum YKL-40 and colorectal cancer. | Q36619099 | ||
| Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer | Q36646351 | ||
| The signaling mechanism of ROS in tumor progression | Q36679538 | ||
| Is YKL-40 a new therapeutic target in cancer? | Q36709555 | ||
| YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling | Q36725097 | ||
| Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses | Q36731284 | ||
| Gene Encoding Chitinase 3-Like 1 Protein (CHI3L1) is a Putative Oncogene | Q36735677 | ||
| Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line | Q38995753 | ||
| Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer. | Q39009341 | ||
| The chitinase-like protein YKL-40 increases mucin5AC production in human bronchial epithelial cells | Q39102021 | ||
| The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma | Q39176294 | ||
| YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration | Q39235588 | ||
| High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis | Q39364301 | ||
| Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. | Q39497650 | ||
| Silencing IL-13Rα2 promotes glioblastoma cell death via endogenous signaling | Q39539596 | ||
| Association between YKL-40 and adult primary astrocytoma | Q39700712 | ||
| YKL-40, a secreted glycoprotein, promotes tumor angiogenesis | Q39797155 | ||
| IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses | Q39797207 | ||
| Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C. | Q39840925 | ||
| YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages | Q39938215 | ||
| Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. | Q39950004 | ||
| Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein | Q39980523 | ||
| Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma | Q40252227 | ||
| CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma | Q40410464 | ||
| CHI3L1 nuclear localization in monocyte derived dendritic cells. | Q40432115 | ||
| Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. | Q40443893 | ||
| Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease | Q40537192 | ||
| YKL-40 as marker of severe lung disease in cystic fibrosis patients. | Q40829237 | ||
| Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies | Q40847064 | ||
| Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications | Q40896469 | ||
| Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. | Q40994644 | ||
| YKL-40 acts as an angiogenic factor to promote tumor angiogenesis | Q41073254 | ||
| Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction | Q41133816 | ||
| The Role of MicroRNA, miR-24, and Its Target CHI3L1 in Osteomyelitis Caused by Staphylococcus aureus | Q41229601 | ||
| The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha | Q42050319 | ||
| Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects. | Q42241520 | ||
| Diagnosis of cardiac surgery-associated acute kidney injury: differential roles of creatinine, chitinase 3-like protein 1 and neutrophil gelatinase-associated lipocalin: a prospective cohort study | Q42318966 | ||
| Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus | Q42362647 | ||
| The glial marker YKL-40 is decreased in synucleinopathies | Q42441318 | ||
| Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes | Q42456377 | ||
| Serum YKL-40 Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure | Q42833961 | ||
| Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. | Q42981171 | ||
| Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer | Q43011817 | ||
| CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. | Q43053159 | ||
| Increased YKL-40 expression in patients with carotid atherosclerosis | Q43116827 | ||
| YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. | Q43519963 | ||
| Regulation of YKL-40 production by human articular chondrocytes | Q43584273 | ||
| Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells. | Q43669802 | ||
| YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes | Q43684361 | ||
| Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression. | Q43753094 | ||
| Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis. | Q44076085 | ||
| Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. | Q44520884 | ||
| Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. | Q44559401 | ||
| Identification of proteins secreted by human osteoblastic cells in culture | Q46128068 | ||
| YKL-40 identified by proteomic analysis as a biomarker of sepsis | Q46131458 | ||
| Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells | Q46383598 | ||
| YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. | Q46834467 | ||
| Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period | Q70372737 | ||
| Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer | Q71784066 | ||
| Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer | Q73267495 | ||
| YKL-40 in giant cells and macrophages from patients with giant cell arteritis | Q73313545 | ||
| The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis | Q73332383 | ||
| Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis | Q73414197 | ||
| Serum YKL-40 is increased in patients with hepatic fibrosis | Q74012591 | ||
| Chondrex: new marker of joint disease | Q74338979 | ||
| Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary | Q74339345 | ||
| YKL-39, a human cartilage-related protein, induces arthritis in mice | Q74423906 | ||
| Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters | Q77489800 | ||
| IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses | Q77899699 | ||
| The distribution of YKL-40 in osteoarthritic and normal human articular cartilage | Q77918676 | ||
| High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer | Q79157507 | ||
| A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker | Q79607597 | ||
| Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis | Q80231508 | ||
| Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival | Q80421964 | ||
| Increased expression of the inflammatory protein YKL-40 in precancers of the breast | Q80471046 | ||
| Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia | Q80482812 | ||
| High serum YKL-40 level in patients with small cell lung cancer is related to early death | Q80997430 | ||
| Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value | Q81270235 | ||
| High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia | Q81639135 | ||
| Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer | Q81648019 | ||
| Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma | Q82056996 | ||
| Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma | Q82161711 | ||
| Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease | Q82427800 | ||
| YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients | Q82894776 | ||
| Role of YKL-40 in bronchial smooth muscle remodeling in asthma | Q83334872 | ||
| Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis | Q83936030 | ||
| YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E | Q83964900 | ||
| YKL-40 secreted from adipose tissue inhibits degradation of type I collagen | Q84375015 | ||
| Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease | Q84781540 | ||
| Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery | Q84809583 | ||
| Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma | Q84943604 | ||
| YKL‐40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis | Q85029171 | ||
| A repertoire of biomarkers helps in detection and assessment of therapeutic response in epithelial ovarian cancer | Q86558470 | ||
| Allergen induced pulmonary inflammation enhances mammary tumor growth and metastasis: Role of CHI3L1 | Q86916023 | ||
| Elevated Serum Concentration of Chitinase 3-Like 1 is an Independent Prognostic Biomarker for Poor Survival in Lung Cancer Patients | Q87192810 | ||
| Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension | Q87579958 | ||
| YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients | Q88758492 | ||
| Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD | Q89947074 | ||
| Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease | Q89958702 | ||
| Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration | Q91054498 | ||
| Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer | Q91236192 | ||
| Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody | Q91438069 | ||
| Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis | Q92764096 | ||
| Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma | Q46926442 | ||
| YKL-40 is elevated in morbidly obese patients and declines after weight loss. | Q47176179 | ||
| A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40. | Q47254535 | ||
| Chitinase 3-like-1 Promotes Intrahepatic Activation of Coagulation Through Induction of Tissue Factor in Mice. | Q47291910 | ||
| Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass | Q47410039 | ||
| Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation. | Q47754245 | ||
| YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils | Q47756516 | ||
| Chitinase-3-like protein-1 (YKL-40) as a marker of endothelial dysfunction in obstructive sleep apnea | Q47795736 | ||
| Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice | Q47855094 | ||
| Interleukin-8 in cancer pathogenesis, treatment and follow-up | Q47864505 | ||
| Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer | Q47956315 | ||
| Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis. | Q48102914 | ||
| Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma | Q48523844 | ||
| Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma | Q48595349 | ||
| The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure | Q48736245 | ||
| YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma | Q48904499 | ||
| CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD. | Q48939866 | ||
| Chi3l1 regulates APAP-induced liver injury by promoting macrophage infiltration | Q92835126 | ||
| Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population | Q92877141 | ||
| Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography | Q93092398 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 201 | |
| P577 | publication date | 2020-09-14 | |
| P1433 | published in | Signal Transduction and Targeted Therapy | Q108821959 |
| P1476 | title | Chitinase-3 like-protein-1 function and its role in diseases | |
| P478 | volume | 5 |
| Q106464187 | Multi-organ proteomic landscape of COVID-19 autopsies | cites work | P2860 |
Search more.